Profil
Richard C.
Duke was the founder of GlobeImmune, Inc., founded in 1995, where the title held was President & Chief Executive Officer from 1995 to 2013.
Dr. Duke is the founder of ApopLogic Pharmaceuticals, Inc., founded in 2006, where the title held is President & Chief Executive Officer.
Dr. Duke is also the founder of Colorado Institute For Drug Device & Diagnostic Development.
Dr. Duke is currently Chairman & Chief Executive Officer at MenoGenix, Inc. Dr. Duke is currently Associate Professor at The University of Colorado.
Former positions include Chairman & Chief Executive Officer at Peptivir, Inc. and Director at Sierra Neuropharmaceuticals, Inc. Education includes an undergraduate degree from McGill University in 1978, a graduate degree from McGill University in 1981, and a doctorate from The University of Colorado in 1985.
Aktive Positionen von Richard Duke
| Unternehmen | Position | Beginn |
|---|---|---|
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
ApopLogic Pharmaceuticals, Inc.
ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Vorstandsvorsitzender | 01.01.2006 |
MenoGenix, Inc.
MenoGenix, Inc. BiotechnologyHealth Technology Develops drugs for breast and prostate cancer | Vorstandsvorsitzender | - |
Ehemalige bekannte Positionen von Richard Duke
| Unternehmen | Position | Ende |
|---|---|---|
Colorado Institute For Drug Device & Diagnostic Development
Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services Provides health maintenance services | Gründer | - |
Sierra Neuropharmaceuticals, Inc.
Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Direktor/Vorstandsmitglied | - |
Peptivir, Inc.
Peptivir, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops synthetic peptide-based vaccine platform for the prevention of viral diseases | Vorstandsvorsitzender | - |
| GLOBEIMMUNE, INC. | Gründer | - |
Ausbildung von Richard Duke
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
GlobeImmune, Inc.
GlobeImmune, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops therapeutic products for cancer and infectious diseases | Health Technology |
Sierra Neuropharmaceuticals, Inc.
Sierra Neuropharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical products | Health Technology |
ApopLogic Pharmaceuticals, Inc.
ApopLogic Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops pharmaceutical products | Health Technology |
Peptivir, Inc.
Peptivir, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops synthetic peptide-based vaccine platform for the prevention of viral diseases | Health Technology |
MenoGenix, Inc.
MenoGenix, Inc. BiotechnologyHealth Technology Develops drugs for breast and prostate cancer | Health Technology |
McGill University
McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Colorado
The University of Colorado Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Colorado Institute For Drug Device & Diagnostic Development
Colorado Institute For Drug Device & Diagnostic Development Medical/Nursing ServicesHealth Services Provides health maintenance services | Health Services |
















